Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to…

Read more →

There are a variety of healthcare professionals that can help manage diabetes. Knowing what to expect from each will help you make the most of your visit.

Read more →

Teens and young adults with type 2 diabetes develop kidney, nerve, and eye diseases – as well as some risk factors for heart disease – more often than their peers with type 1 diabetes in the years…

Read more →

In a study published online by JAMA Ophthalmology, Paul D. Loprinzi, Ph.D., of the University of Mississippi, University, Miss.

Read more →

Mouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds.

Read more →

Researchers at Queen’s University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes…

Read more →

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than…

Read more →

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut…

Read more →

Diabetes can cause blurry vision for many reasons. Learn about the short-term and long-term complications that can affect vision in people with diabetes.

Read more →

Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in…

Read more →

A number of complications are associated with diabetes, but they are more prevalent in some patients than in others.

Read more →

Two new risk prediction tools can identify patients with diabetes who are at high risk of blindness and amputation – two serious complications of diabetes, finds a study published in The BMJ this…

Read more →

Data from a new study shows that ranibizumab (Lucentis®) used in a treat-and-extend (T&E) regimen cuts clinic visits by 46% for patients with Diabetic Macular Oedema (DMO) – one of the leading…

Read more →

A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their…

Read more →

Findings by Joslin researchers may lead to early detection and treatment of complicationsJoslin scientists have advanced understanding of how the cellular repair process is impaired in type 1…

Read more →

Evaluation a key step in creation of treatment for disease that affects millionsUniversity of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use…

Read more →

The National Institute for Health and Care Excellence (NICE) draft Final Appraisal Determination (FAD) recommends EYLEA for the treatment of patients with visual impairment due to diabetic macular…

Read more →

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study…

Read more →

New research published in the Journal of American Medical Association indicates that current EU guidelines on how and when to lower blood pressure for diabetes patients, could increase the risk of…

Read more →

Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic retinopathy (DR) in…

Read more →